Oculis
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Oculis and other ETFs, options, and stocks.About OCS
Oculis Holding AG is a global biopharmaceutical company, which engages in sight and improving eye care. The firm's pipeline includes multiple product candidates in development such as, OCS-01, a topical retinal candidate for diabetic macular edema, OCS-02, a topical biologic candidate for dry eye disease, and OCS-05, a disease modifying candidate for acute optic neuritis and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.
CEORiad Sherif
CEORiad Sherif
Employees49
Employees49
HeadquartersZug, Zug
HeadquartersZug, Zug
Founded2016
Founded2016
Employees49
Employees49
OCS Key Statistics
Market cap816.00M
Market cap816.00M
Price-Earnings ratio-7.11
Price-Earnings ratio-7.11
Dividend yield—
Dividend yield—
Average volume27.35K
Average volume27.35K
High today$18.04
High today$18.04
Low today$16.77
Low today$16.77
Open price$18.04
Open price$18.04
Volume63.48K
Volume63.48K
52 Week high$23.08
52 Week high$23.08
52 Week low$10.79
52 Week low$10.79
Analyst ratings
100%
of 8 ratingsBuy
100%
Hold
0%
Sell
0%